Skip to main content
. 2019 Aug 13;52(2):374–387. doi: 10.4143/crt.2019.198

Fig. 1.

Fig. 1.

(A) Swimmer plot for clinical course and duration of response in all patients. (B) Waterfall plot of percent change from baseline tumor size in all patients. DLBCL, diffuse large B-cell lymphoma; PMBCL, primary mediastinal B-cell lymphoma; PTCL-NOS, peripheral T-cell lymphoma not otherwise specified; AITL, angioimmunoblastic T-cell lymphoma; tMF, transformed mycosis fungoides; ENKTL, extranodal natural killer/T-cell lymphoma; BV, brentuximab vedotin.